These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 352667)
41. [Non steroidal anti-inflammatory drugs and rheumatic diseases]. Cossermelli W; Pastor EH Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(2):115-24. PubMed ID: 7569599 [TBL] [Abstract][Full Text] [Related]
42. [Clinical control of the therapeutic action of a decontracting, anti-rheumatic, analgesic drug combination for topical use, in comparison with oxyphenbutazone]. Magnanini R; Mazzoni G; Musiani M; Orlandi V; D'Antonio C Clin Ter; 1982 Apr; 101(2):151-65. PubMed ID: 6980084 [No Abstract] [Full Text] [Related]
43. [Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients]. Lemmel EM; Stroehmann I Fortschr Med; 1988 Apr; 106(12):253-6. PubMed ID: 3260888 [No Abstract] [Full Text] [Related]
44. Therapeutic choices for rheumatic disorders. Hughes G Gerontology; 1988; 34 Suppl 1():27-32. PubMed ID: 2977119 [TBL] [Abstract][Full Text] [Related]
45. Comparative study of sulindac (Clinoril) and ibuprofen (Brufen) in osteoarthrosis. Brackertz B; Busson M Br J Clin Pract; 1978 Mar; 32(3):77-80. PubMed ID: 352382 [No Abstract] [Full Text] [Related]
47. [Ketoprofen--a first class nonsteroidal anti-arrhythmia agent]. Z Orthop Ihre Grenzgeb; 1997; 135(1 Suppl):1-8. PubMed ID: 9209544 [No Abstract] [Full Text] [Related]
48. A multicenter trial of sulindac in osteoarthritis of the hip. Calabro JJ; Andelman SY; Caldwell JR; Gerber RC; Hamaty D; Kaplan H; Maltz BA; Parsons JL; Saville P; Tretbar HC; Ward JR Clin Pharmacol Ther; 1977 Sep; 22(3):358-63. PubMed ID: 330080 [TBL] [Abstract][Full Text] [Related]
49. [Clinical study with isonixine]. Asensi E; Barceló P Rev Esp Reum Enferm Osteoartic; 1977; 20(2):159-67. PubMed ID: 327518 [No Abstract] [Full Text] [Related]
50. [Ground rules in pharmacotherapy of rheumatic diseases]. Wessel G; Reinicke C Z Gesamte Inn Med; 1980 Nov; 35(22):suppl 157-60. PubMed ID: 6970456 [No Abstract] [Full Text] [Related]
51. Phosphodiesterase inhibitor pentoxifylline: an antiinflammatory/immunomodulatory drug potentially useful in some rheumatic diseases. Anaya JM; Espinoza LR J Rheumatol; 1995 Apr; 22(4):595-9. PubMed ID: 7791149 [No Abstract] [Full Text] [Related]
53. Drug interactions in rheumatoid disease--are they of any clinical importance? Volans GN Rheumatol Rehabil; 1978; Suppl():112-7. PubMed ID: 364601 [TBL] [Abstract][Full Text] [Related]
55. Drug therapy in the rheumatic diseases. Reardon EV; Clough JD Compr Ther; 1992 Nov; 18(11):22-5. PubMed ID: 1478055 [No Abstract] [Full Text] [Related]
56. A controlled clinical study comparing sulindac with ibuprofen and aspirin in the treatment of musculo-skeletal diseases. Oyemade GA; Onadeko BO J Int Med Res; 1979; 7(6):556-9. PubMed ID: 160348 [TBL] [Abstract][Full Text] [Related]
57. [Compliance to therapy in daily practice--rheumatologic diseases]. Gerster JC Schweiz Rundsch Med Prax; 1993 Nov; 82(48):1381-3. PubMed ID: 8296118 [TBL] [Abstract][Full Text] [Related]
58. [Mesalazine]. Engelhardt K; Mohr K Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502 [No Abstract] [Full Text] [Related]
59. Droxicam: a pharmacological and clinical review of a new NSAID. Jané F; Rodríguez de la Serna A Eur J Rheumatol Inflamm; 1991; 11(4):3-9. PubMed ID: 1365488 [TBL] [Abstract][Full Text] [Related]